References of "Coutant, K"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailInfluence of baseline patient characteristics on response to one-monthly and daily oral ibandronate therapy: 2-year findings from MOBILE
Reginster, Jean-Yves ULg; Hawker, G.; Bolognese, M. et al

in Annals of the Rheumatic Diseases (2006, June), 65(Suppl.II), 426

Detailed reference viewed: 9 (3 ULg)
Full Text
Peer Reviewed
See detailOnce-monthly dosing of oral ibandronate is highly efficacious: 2-year results from mobile
Reginster, Jean-Yves ULg; Stakkestad, J. A.; Lorenc, R. et al

in Osteoporosis International (2006, March), 17(Suppl.1), 64-65

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detailMonthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis : 1-year results from mobile
Cooper, C.; Stepan, J. J.; Lorenc, R. et al

in BONE (2005), 36(S2), 417

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailA novel bisphosphonate dosing regimen: once-monthly oral ibandronate
Cooper, C.; Adami, Silvio; Stepan, J. J. et al

in Annals of the Rheumatic Diseases (2004, June)

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailOnce-monthly oral ibandronate a new bisphosphonate dosing concept
Reginster, Jean-Yves ULg; Miller, P.; Delmas, P. et al

in Calcified Tissue International (2004), 74(S1), 85

Detailed reference viewed: 4 (2 ULg)
Full Text
Peer Reviewed
See detailOral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis
Reginster, Jean-Yves ULg; McClung, M.; Coutant, K. et al

in Annals of the Rheumatic Diseases (2003, June)

Detailed reference viewed: 24 (11 ULg)